BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37298647)

  • 1. SPINK2 Protein Expression Is an Independent Adverse Prognostic Marker in AML and Is Potentially Implicated in the Regulation of Ferroptosis and Immune Response.
    Pitts HA; Cheng CK; Cheung JS; Sun MK; Yung YL; Chan HY; Wong RSM; Yip SF; Lau KN; Wong WS; Raghupathy R; Chan NPH; Ng MHL
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPINK2 is a prognostic biomarker related to immune infiltration in acute myeloid leukemia.
    Chen X; Zhao L; Yu T; Zeng J; Chen M
    Am J Transl Res; 2022; 14(1):197-210. PubMed ID: 35173838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of SPINK2 in acute myeloid leukemia.
    Gezer S; Emrence Z; Elverdi T; Ar MC; Salman Yaylaz B; Paçal F; Ünüvar A; Sarıman M; Eşkazan AE; Karaman S; Salihoğlu A; Karakaş Z; Abacı N; Sırma-Ekmekci S
    Adv Lab Med; 2023 Apr; 4(1):92-104. PubMed ID: 37359898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIVEP3 cooperates with ferroptosis gene signatures to confer adverse prognosis in acute myeloid leukemia.
    Zhang X; Zhang X; Liu K; Li W; Wang J; Liu P; Ma W
    Cancer Med; 2022 Dec; 11(24):5050-5065. PubMed ID: 35535739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
    Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
    BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated SPINK2 gene expression is a predictor of poor prognosis in acute myeloid leukemia.
    Xue C; Zhang J; Zhang G; Xue Y; Zhang G; Wu X
    Oncol Lett; 2019 Sep; 18(3):2877-2884. PubMed ID: 31452767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of a novel CD8+ T cell-associated prognostic model based on ferroptosis in acute myeloid leukemia.
    Jiang G; Jin P; Xiao X; Shen J; Li R; Zhang Y; Li X; Xue K; Li J
    Front Immunol; 2023; 14():1149513. PubMed ID: 37138885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of ferroptosis-related gene signatures as a potential therapeutic target for acute myeloid leukemia: A bioinformatics analysis and experimental verification.
    Zheng Z; Hong X; Huang X; Jiang X; Jiang H; Huang Y; Wu W; Xue Y; Lin D
    Front Oncol; 2022; 12():930654. PubMed ID: 36033479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification of acute myeloid leukemia: Assessment using a novel prediction model based on ferroptosis-immune related genes.
    Guo X; Zhou X
    Math Biosci Eng; 2022 Aug; 19(12):11821-11839. PubMed ID: 36653976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of ferroptosis-related genes and their methylation in AML.
    Zhou F; Chen B
    Hematology; 2021 Dec; 26(1):919-930. PubMed ID: 34789073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
    Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
    J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic mechanisms and novel potential therapeutic targets for ferroptosis in acute myeloid leukemia.
    Tang X; Wang Y; Zhu Y; Guo Y; Liu B
    Ann Hematol; 2023 Aug; 102(8):1985-1999. PubMed ID: 37314462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel ferroptosis-related gene signature can predict prognosis and influence immune microenvironment in acute myeloid leukemia.
    Huang X; Zhou D; Ye X; Jin J
    Bosn J Basic Med Sci; 2022 Jul; 22(4):608-628. PubMed ID: 34784264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a prognostic ferroptosis-related gene profile in acute myeloid leukaemia.
    Shao R; Wang H; Liu W; Wang J; Lu S; Tang H; Lu Y
    J Cell Mol Med; 2021 Dec; 25(23):10950-10960. PubMed ID: 34741393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3-internal tandem duplication genotypes.
    Boddu PC; Kadia TM; Garcia-Manero G; Cortes J; Alfayez M; Borthakur G; Konopleva M; Jabbour EJ; Daver NG; DiNardo CD; Naqvi K; Yilmaz M; Short NJ; Pierce S; Kantarjian HM; Ravandi F
    Cancer; 2019 Apr; 125(7):1091-1100. PubMed ID: 30521114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia.
    Zhou L; Jia X; Shang Y; Sun Y; Liu Z; Liu J; Jiang W; Deng S; Yao Q; Chen J; Li H
    Mol Carcinog; 2023 Aug; 62(8):1119-1135. PubMed ID: 37144835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin.
    Du J; Wang T; Li Y; Zhou Y; Wang X; Yu X; Ren X; An Y; Wu Y; Sun W; Fan W; Zhu Q; Wang Y; Tong X
    Free Radic Biol Med; 2019 Feb; 131():356-369. PubMed ID: 30557609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APR-246 induces early cell death by ferroptosis in acute myeloid leukemia.
    Birsen R; Larrue C; Decroocq J; Johnson N; Guiraud N; Gotanegre M; Cantero-Aguilar L; Grignano E; Huynh T; Fontenay M; Kosmider O; Mayeux P; Chapuis N; Sarry JE; Tamburini J; Bouscary D
    Haematologica; 2022 Feb; 107(2):403-416. PubMed ID: 33406814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired spermatogenesis and fertility in mice carrying a mutation in the Spink2 gene expressed predominantly in testes.
    Lee B; Park I; Jin S; Choi H; Kwon JT; Kim J; Jeong J; Cho BN; Eddy EM; Cho C
    J Biol Chem; 2011 Aug; 286(33):29108-29117. PubMed ID: 21705336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.
    Chretien AS; Fauriat C; Orlanducci F; Rey J; Borg GB; Gautherot E; Granjeaud S; Demerle C; Hamel JF; Cerwenka A; von Strandmann EP; Ifrah N; Lacombe C; Cornillet-Lefebvre P; Delaunay J; Toubert A; Arnoulet C; Vey N; Olive D
    Oncotarget; 2017 Jul; 8(30):49548-49563. PubMed ID: 28548938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.